Keyphrases
90-day Mortality
24%
ABO Blood Group
14%
Antimicrobial
14%
Bilirubin
15%
Bleeding Events
15%
Blood Type
14%
Bloodstream Infection
14%
C-reactive Protein
14%
Comorbidity
15%
Confidence Interval
43%
Coronavirus Disease (COVID)
19%
COVID-19
100%
Critically Ill Patients
94%
Denmark
63%
Endothelial Damage
23%
Guided Intervention
14%
Guideline-directed Medical Therapy
14%
Hazard Ratio
28%
High-dose Corticosteroids
14%
ICU Admission
20%
ICU Patients
37%
Induced Hypothermia
42%
Injury Biomarkers
14%
Intensive Care
27%
Intensive Care Patients
19%
Intensive Care Unit
48%
Intensive Care Unit Patients
42%
Length of Stay
18%
Leukocytes
14%
Long-term Survival
17%
Low-dose Hydrocortisone
14%
Mean Arterial Pressure
14%
Mechanical Ventilation
24%
Nationwide Observational Study
56%
Nonrecovery
14%
Out-of-hospital Cardiac Arrest
42%
Patient Data
28%
Patients with COVID-19
59%
Population-based Cohort Study
28%
Procalcitonin
45%
Prognostic Factors
14%
Randomized Clinical Trial
14%
Randomized Controlled Trial
46%
Randomized Trial
62%
Resource Use
17%
Sepsis
54%
Sepsis Mortality
14%
Septic Shock
37%
Thrombocytopenia
14%
Ventricular Arrhythmia
14%
Medicine and Dentistry
Acute Kidney Injury
14%
Acute Respiratory Distress Syndrome
14%
Acute Respiratory Failure
14%
All Cause Mortality
15%
Antibiotics
23%
Arm
14%
Artificial Respiration
28%
Atrial Fibrillation
14%
Bilirubin
11%
Biological Marker
41%
Broad-Spectrum Antibiotic
14%
Charlson Comorbidity Index
9%
Cohort Analysis
16%
COVID-19
99%
Drug Megadose
14%
Functional Status
14%
Glucocorticoid
14%
Hazard Ratio
26%
Heart Arrest
14%
Hemodynamic
14%
Hydrocortisone
14%
Hypoxia
14%
Induced Hypothermia
28%
Infection
19%
Intensive Care
46%
Intensive Care Unit
92%
Long Term Survival
15%
Low Drug Dose
14%
Lung Injury
14%
Mean Arterial Pressure
12%
Observational Study
56%
Open-Label Trial
14%
Out of Hospital Cardiac Arrest
28%
Placebo
8%
Procalcitonin
25%
Prognostic Factor
14%
Quality of Life
8%
Renal Failure
14%
Renal Replacement Therapy
9%
Respiratory Failure
17%
Restylane
14%
Sepsis
55%
Septic Shock
35%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Surfactant Protein D
14%
Syndecan 1
15%
Targeted Temperature Management
14%
Thrombocyte Function
14%
Thromboembolism
15%
Thrombomodulin
17%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
14%
Acute Respiratory Failure
14%
Adult Respiratory Distress Syndrome
14%
All Cause Mortality
16%
Antibiotic Agent
34%
Antibiotic Therapy
8%
Antibiotics
18%
Antiinfective Agent
35%
Bilirubin
14%
Biological Marker
55%
Bloodstream Infection
14%
C Reactive Protein
14%
Candidiasis
14%
Cefuroxime
14%
Ciprofloxacin
14%
Clinical Trial
9%
Cohort Study
35%
Coronavirinae
49%
Disease
56%
Frailty
14%
Functional Status
14%
Glucocorticoid
14%
Heart Arrest
18%
Heart Arrhythmia
14%
Hyaluronic Acid
14%
Hydrocortisone
14%
Hypoxia
14%
Infection
16%
Interleukin 6
11%
Kidney Failure
14%
Long Term Survival
14%
Lung Injury
14%
Meropenem
14%
Methylprednisolone
16%
Neuron Specific Enolase
11%
Observational Study
14%
Out of Hospital Cardiac Arrest
42%
Piperacillin Plus Tazobactam
14%
Placebo
27%
Procalcitonin
45%
Randomized Clinical Trial
14%
Randomized Controlled Trial
30%
SARS Coronavirus
9%
Sepsis
49%
Septic Shock
7%
Surfactant Protein D
14%
Syndecan 1
15%
Thrombocytopenia
14%
Thromboembolism
14%
Thrombomodulin
17%
